Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Insulin therapy in type 2 diabetes].

J C Philips1, A J Scheen

  • 1Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine, CHU Sart Tilman, Liège.

Revue Medicale De Liege
|July 23, 2005
PubMed
Summary

Insulin therapy is crucial for type 2 diabetes patients who don't respond to oral medications. Optimal metabolic control in type 2 diabetes depends on patient education and close monitoring, not just the insulin regimen.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Context:

  • Type 2 diabetes management often involves a delayed introduction of insulin therapy after failure of oral antidiabetic drugs.
  • Current insulin therapy for type 2 diabetes is less standardized compared to type 1 diabetes.
  • Clinical trials aim to define optimal initial insulin strategies for type 2 diabetes to achieve normoglycemia without significant hypoglycemia.

Purpose:

  • To explore the most appropriate initial insulin therapy for type 2 diabetic patients.
  • To achieve near-normal blood glucose levels while minimizing hypoglycemia risk.
  • To address the lack of consensus on the optimal method for initiating insulin therapy.

Summary:

  • Type 2 diabetes patients failing oral antidiabetic agents require insulin therapy.
  • Initiating insulin therapy in type 2 diabetes lacks standardization.
  • Effective metabolic control hinges on comprehensive patient education and intensified follow-up, irrespective of the specific insulin regimen.

Impact:

  • Highlights the importance of patient education and monitoring for type 2 diabetes management.
  • Suggests that a standardized approach to insulin initiation may be less critical than supportive care.
  • Informs clinical practice regarding the management of type 2 diabetes refractory to oral medications.

Related Experiment Videos